Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by cyclooxygenase inhibitors

International Journal of Angiology

Volumn 12, Issue 1, 2003, Pages 13-23

  Lee, Paul ^a   Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDOMETACIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NAPROXEN; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DRUG EFFECT; FEMALE; HYPERCHOLESTEROLEMIA; LEUKOCYTE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0141455921     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00547-003-0976-4     Document Type: Article

References (44)

1. Prasad K, Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 125:958-973.
2. Prasad K, Kalra J, Lee P (1994) Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of probucol. Int J Angiol 3:100-112.
3. Steinberg D (1992) Antioxidants in the prevention of human atherosclerosis. Circulation 85:2338-2345.
4. Prasad K (1999) Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99:1355-1362.
5. Görg P, Kakkar VV (1987) Increased uptake of monocyte-treated low density lipoproteins by aortic endothelium in vivo. Atherosclerosis 65:99-107.
6. 2 by platelets in vitro. N Engl J Med 302:6-10.
7. Prisco D, Rogasi PG, Matucci M, Pannicia R, Abbate R, Gensini GF, Serneri GG (1986) Age related changes in platelet lipid composition. Thromb Res 44:427-437.
8. Shattil SJ, Anaya-Galindo R, Bennet J, Colman RW, Cooper RA (1975) Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 55:636-643.
9. Mosconi C, Colli S, Tremoli E, Galli C (1988) Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes of type IIa hypercholesterolemic subjects. Atherosclerosis 72:129-134.
10. Ruzicka T, Printz MP (1984) Arachidonic acid metabolism in skin: a review. Rev Physiol Biochem Pharmacol 100:121-160.
11. Vanden Bosch H (1980) Intracellular phospholipases A. Biochem Biophys Acta 604:191-246.
12. ++ concentration and plasma cholesterol in untreated hypertensives. J Hypertension 5(Suppl 5):S251-254.
13. Shattil SJ, Cooper RA (1978) Role of membrane lipid composition, organization, and fluidity in human platelet function. Progr Hemost Thromb 4:59-86.
14. Arendt RM, Wilbert-Lampen U, Heucke L, Schmoeckel M, Suhler K, Richter WO (1993) Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Res Exp Med Bert 193:225-230.
15. Egan RW, Paxton J, Kuehl FA Jr (1976) Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 251:7329-7335.
16. Marnett LJ, Wlodawer P, Samuelsson B (1975) Co-oxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland. J Biol Chem 250:8510-8517.
17. Panganamala RV, Sharma HM, Heikkila RE, Geer JC, Cornwell DG (1976) Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohol and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins 11:599-607.
18. Murota SI, Monta I, Suda N (1990) The control of vascular endothelial injury. Ann NY Acad Sci 598:182-187.
19. Tremoli E, Folco G, Agradi E, Galli C (1979) Platelet thromboxanes and serum cholesterol. Lancet 1:107-108.
20. Henriksson P, Stamberger M, Diezfalusy U (1987) Increased aortic thromboxane production in experimental atherosclerosis. Prostaglandins Leukot Med 29:71-77.
21. Vane JR, Botting R (1987) Inflammation and mechanism of action of antiinflammatory drugs. FASEB J 1:89-96.
22. Cryer B, Feldman M (1998) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidat anti-inflammatory drugs. Am J Med 104:413-421.
23. Higgs GA, Flower RJ, Vane JR (1979) A new approach to antiinflammatory drugs. Biochem Pharmcol 28:1959-1961.
24. Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R, Santucci L, Wallace JL, Cirino G (2000) NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Brit J Pharmacol 130:1399-1405.
25. Stanfield KM, Khan KN, Gralinski MR (2001) Localization of cyclooxygenase isozymes in cardiovascular tissue of dogs treated with naproxen. Vet Immunol Immunopathol 80:309-314.
26. Prasad K, Mantha SV, Muir AD, Westcott ND (1998) Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136:367-375.
27. Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B (1996) Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28:375-385.
28. Kapoor R, Prasad K (1994) Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: effect of SOD and catalase. Circ Shock 43:79-94.
29. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351-358.
30. Holman RS, McGill HC Jr, Strong JP, Greet JC (1958) Technics for studying atherosclerotic lesions. Lab Invest 7:42-47.
31. Knowles DM (2001) Immunophenotypic markers useful in the diagnosis and classification of hemopoietic neoplasm. In: Knowles DM (ed) Neoplastic Hematopathology. Lippincott-William: Philadelphia, pp 93-226
32. Prasad K (1997) Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132:69-76.
33. Prasad K, Kalra J, Chaudhary AK, Debnath D (1990) Effect of polymorphonuclear leukocyte-derived oxygen free radicals and hypochtorous acid on cardiac function and some biochemical parameters. Am Heart J 119:538-550.
34. Gornall AG, Bardwill CJ, David MM (1949) Determination of serum proteins by means of biuret reaction. J Biol Chem 177:751-766.
35. Prasad K, Laxdal VA (1994) Hydroxyl radical-scavenging property of indomethacin. J Mol Cell Biochem 136:139-144.
36. Pal S, Bursill C, Bottema C, Roach PD (1999) Regulation of the low-density lipoprotein receptor by antioxidants. In: Basu TK, Temple NL, Garg M (eds). Antioxidants in Human Health and Disease: CABI Publishing: Oxford, UK, pp 55-69.
37. Prasad K, Mantha SV, Kalra J, Kapoor R, Kamalarajan BRC (1997) Purpurogallin in the prevention of hypercholesterolemic atherosclerosis. Int J Angiol 6:157-166.
38. Prasad K, Mantha SV, Kalra J, Lee P (1997) Prevention of hypercholesterolemic atherosclerosis by garlic, an antioxidant. J Cardiovasc Pharmacol Therapeut 2:309-320.
39. Mantha SV, Prasad M, Kalra J, Prasad K (1993) Antioxidant enzymes in hypercholesterolemia and effects of vitamin E. Atherosclerosis 101:135-144.
40. Prasad K, Lee P, Mantha SV, Kalra J, Prasad M, Gupta JB (1992) Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence. Mol Cell Biochem 115:49-58.
41. Kapoor R, Prasad K (1996) Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Rad Biol Med 21:609-618.
42. Warren JS, Ward PA (1983) Oxidative injury to vascular endothelium. Am J Med Sci 292:97-103.
43. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 61:1161-1167.
44. Ross R (1986) The pathogenesis of atherosclerosis: an update. N Engl J Med 314:488-500.